NOVONIX (FRA:GC3) Change In Receivables: €0.00 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:GC3 NOVONIX Ltd FRA:GC3
37 GF Score
Price €0.09
! 4 Warning Signs
View Full Analysis

What is NOVONIX Change In Receivables?

NOVONIX FRA:GC3 +0.35% 37 Change In Receivables is €0.00 Mil as of Dec. 2025. GuruFocus rates FRA:GC3 with a GF Score™ of 37/100. The stock has 4 warning signs investors should review.

NOVONIX's change in receivables for the quarter that ended in Dec. 2025 was €0.00 Mil. It means NOVONIX's Accounts Receivable stayed the same from Sep. 2025 to Dec. 2025 .

NOVONIX's change in receivables for the fiscal year that ended in Dec. 2025 was €0.19 Mil. It means NOVONIX's Accounts Receivable declined by €0.19 Mil from Dec. 2024 to Dec. 2025 .

NOVONIX's Accounts Receivable for the quarter that ended in Dec. 2025 was €1.16 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. NOVONIX's liquidation value for the three months ended in Dec. 2025 was €-33.54 Mil.

NOVONIX  (FRA:GC3) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

NOVONIX's Days Sales Outstanding for the quarter that ended in Dec. 2025 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=1.16/0*91
=

2. In Ben Graham's calculation of liquidation value, NOVONIX's accounts receivable are only considered to be worth 75% of book value:

NOVONIX's liquidation value for the quarter that ended in Dec. 2025 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=68.206-103.546+0.75 * 1.16+0.5 * 1.865
=-33.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NOVONIX Change In Receivables Related Terms

NOVONIX Change In Receivables Historical Data

* Premium members only.

The historical data trend for NOVONIX's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NOVONIX Change In Receivables Chart

NOVONIX Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Dec23 Dec24 Dec25
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.35 -0.94 -0.52 1.52 0.19

NOVONIX Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:GC3
37GF Score
NOVONIX Ltd FRA:GC3
Change In Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NOVONIX Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of €0.00 Mil mean?
NOVONIX (FRA:GC3) has a Change In Receivables of €0.00 Mil as of Dec. 2025. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for NOVONIX and its competitors.
Is NOVONIX's Change In Receivables too high?
NOVONIX's current Change In Receivables is €0.00 Mil. Overall, NOVONIX has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does NOVONIX's Change In Receivables compare to VRT and BE?
NOVONIX's Change In Receivables of €0.00 Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for an Industrial Products company?
A good Change In Receivables depends on the Industrial Products industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for NOVONIX and its competitors. NOVONIX's current Change In Receivables is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NOVONIX stock overvalued right now?
NOVONIX (FRA:GC3) has a current Change In Receivables of €0.00 Mil. The current Change In Receivables is €0.00 Mil. NOVONIX's overall GF Score™ is 37/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For NOVONIX (FRA:GC3), the current Change In Receivables is €0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

NOVONIX Business Description

Address 1029 West 19th Street, Chattanooga, TN, USA, 37408
NOVONIX Ltd is a battery technology company developing and scaling materials and equipment critical to the lithium-ion battery supply chain. The company has three operating segments: Battery Materials: It develops and manufactures battery anode materials, ii) Battery Technology: It develops and manufactures battery cell testing equipment, performs consulting services and carries out research and development in battery development, and Graphite Exploration: It manages the maintenance and future development of Mount Dromedary natural graphite deposit. The majority of the company's revenue is derived from the Battery Technology segment. Geographically, the maximum revenue is derived from North America, followed by Asia, and Europe.
37GF Score

Get the complete analysis for FRA:GC3

Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.09
Price